Aafmaa Wealth Management & Trust LLC Novo Nordisk A S Transaction History

Aafmaa Wealth Management & Trust LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 30, 2025	BUY	$45.38 - $71.7 $9,121 - $14,411	201 Added 1.35%	15,130 $839,000
Q2 2025 Jul 16, 2025	SELL	$58.08 - $81.05 $378,855 - $528,689	-6,523 Reduced 30.41%	14,929 $1.03 Million
Q1 2025 Apr 11, 2025	BUY	$69.3 - $90.95 $283,783 - $372,440	4,095 Added 23.59%	21,452 $1.49 Million
Q4 2024 Jan 13, 2025	BUY	$85.0 - $120.04 $384,115 - $542,460	4,519 Added 35.2%	17,357 $1.49 Million
Q3 2024 Oct 16, 2024	BUY	$119.07 - $145.42 $236,711 - $289,094	1,988 Added 18.32%	12,838 $1.53 Million

Q2 2024 Jul 19, 2024	BUY	$122.71 - $146.91 $45,402 - $54,356	370 Added 3.53%	10,850 $1.55 Million
Q1 2024 May 02, 2024	BUY	$102.11 - $135.92 $1.07 Million - $1.42 Million	10,480 New	10,480 $1.35 Million

1,689

303M

25.9M

43.8M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $109B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Aafmaa Wealth Management & Trust LLC, based on Form 13F filings with the SEC.

Stay updated on Aafmaa Wealth Management & Trust LLC with notifications on news.